THE FUTURE OF SWEDISH & DANISH LIFE SCIENCE

September 29 2020, Lund

Welcome to the 9th edition of

The Future of Swedish & Danish Life Science

Collaborations, directions and investments of the future

Life Science in the Öresund region with its thriving ecosystem of cutting-edge science, hundreds of life science companies and investments in research infrastructure, major projects and product development is in a continuous growth mode. The 9th edition of our international partnering event The Future of Swedish & Danish Life Science will showcase the region’s strengths and look at the key factors behind the success of Swedish/Danish life science collaboration. One of the themes will cover the hot topic Immuno-oncology. In other sessions, panels with experts will discuss critical factors for continued, international competitiveness such as how to create value through the unique research infrastructure including Max IV and ESS, how to attract (and keep) competence and how to maintain and further improve the conditions for innovation and product development.

Take the opportunity to join our panel discussions at The Future of Swedish & Danish Life Science:

  • Pipeline of Swedish and Danish IMMUNO-ONCOLOGY therapies – challenges, possibilities and how to bring new medicines to market
  • Leveraging investments in regional programs/research infrastructure for growth
  • How to attract (and keep) talents and competences in the Medicon Valley region?
  • How can the virtual company model in start-up- and early phase drug development be further developed?
  • How can the partnership with service providers in late stage drug development, IPO and market access program be further improved?

 

The international partnering-event The Future of Swedish & Danish Life Science started in 2012 and includes a combination of partnering (pre-bookable one-on-one meetings), presentations, exhibition and informal networking.These four core elements of the day run in parallel and ensure that the event is a lively, energetic day designed to impart new knowledge and build new networks.


The event attracts 400-500 leading decision makers every year from all over the world from pharma, biotech and medtech as well as research, the healtchcare sector, policy, regulatory authorities and finace. The exhibition with about 30 exhibitors provides a platform for partners and vendors to engage and discuss collaborations and do business.

We hope you will be able to join us for the end of show drinks and refreshments reception, which provides a great opportunity to network with fellow delegates. Combined with the extended lunch break and coffee breaks, delegates will have ample opportunities to touch base on a more informal basis.


Moderator 2020: Lisa Kirsebom, freelancing science journalist and moderator

Coronavirus: Precautions taken by the organizer

The health and safety for visitors and partners is top priority. We take any concerns very seriously and follow the recommendations of The Public Health Agency of Sweden. We are closely monitoring developments. Based on current recommendations, The Future of Swedish & Danish Life Science is going ahead as planned. 

As exhibitors and visitors of The Future of Swedish & Danish Life Science, you can expect a high level of hygiene at the event. At the meeting place, there are signs and instructions encouraging visitors to take extra care in order to prevent infections spreading. 




Medicon Village (Café & Restaurant Inspira)

Date: September 29 2020
Location: Scheeletorget 1, Lund


Register